{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:09:38Z","timestamp":1747760978749},"reference-count":101,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":3994,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS spectr."],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Therapy of bipolar disorders is a rapidly evolving field. Lithium has efficacy in classic bipolar disorders whereas divalproex sodium and carbamazepine may have broader spectrum efficacy that includes non-classic bipolar disorder. In the last 10 years, a series of anticonvulsants have been approved for marketing in the United States. Gabapentin has indirect \u03b3-aminobuytric acid-ergic actions, is generally well tolerated, and appears to have anxiolytic, analgesic, and hypnotic effects. Lamotrigine has antiglutamatergic actions and is generally well tolerated (aside from rash in 1 in 10, and serious rash in 1 in 1,000 patients). Lamotrigine is indicated for maintance treatment in bipolar disorder. Emerging evidence suggests lamotrigine may have utility in bipolar disorder patients with depression and treatment-refractory rapid cycling, as well as analgesic effects. Topiramate and zonisamide may allow both weight loss, while topiramate may have specific efficacy in bulimia, binge eating disorder, and alcohol dependence. Two small studies found oxcarbazepine had similar efficacy to lithium and haloperidol in acute mania. Phenytoin, an older anticonvulsant, may have adjunctive acute mania efficacy. Levetiracetam, a newer anticonvulsant, may be worth exploring and has minimal drug-drug interactions. None of these newer agents has been shown effective in a large placebo controlled trial for acute mania. Although the clinical profiles of these newer anticonvulsants do not appear to overlap markedly with divalproex and carbamazepine (except perhaps for oxcarbazepine), these novel agents may still offer important new options in relieving a variety of specific target symptoms in patients with bipolar disorder.<\/jats:p>","DOI":"10.1017\/s1092852900028704","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T03:26:50Z","timestamp":1470108410000},"page":"930-947","source":"Crossref","is-referenced-by-count":12,"title":["New Anticonvulsant Medication Uses in Bipolar Disorder"],"prefix":"10.1017","volume":"8","author":[{"given":"Po W.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence A.","family":"Ketter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga V.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecylia","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S1092852900028704_ref073","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01123.x"},{"key":"S1092852900028704_ref069","volume-title":"Low dose adjunctive topitamate attenuates weight gain in bipolar disorder patients","author":"Ketter","year":"2000"},{"key":"S1092852900028704_ref049","volume-title":"Low incidence of lamotrigine treatment-emergent rash with dermatology precautions","author":"Chandler","year":"2003"},{"key":"S1092852900028704_ref064","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.2.208"},{"key":"S1092852900028704_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90687-0"},{"key":"S1092852900028704_ref098","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.148"},{"key":"S1092852900028704_ref086","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00779.x"},{"key":"S1092852900028704_ref039","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00008"},{"key":"S1092852900028704_ref090","first-page":"CD001416","article-title":"Zonisamide add-on for drug-resistant partial epilepsy","author":"Chadwick","year":"2002","journal-title":"Cochrane Database Syst Rev."},{"key":"S1092852900028704_ref043","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0203"},{"key":"S1092852900028704_ref054","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(98)80074-5"},{"key":"S1092852900028704_ref004","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0278-5846(92)90062-J","article-title":"GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium val-proate","volume":"16","author":"Motohashi","year":"1992","journal-title":"Prog Neuropsychpharmacol Biol Psychiatry"},{"key":"S1092852900028704_ref056","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb02163.x"},{"key":"S1092852900028704_ref078","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(96)80111-7"},{"key":"S1092852900028704_ref065","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01189.x"},{"key":"S1092852900028704_ref051","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(92)90049-Y"},{"key":"S1092852900028704_ref097","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(00)00158-3"},{"key":"S1092852900028704_ref034","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.01211.x"},{"key":"S1092852900028704_ref084","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb05939.x"},{"key":"S1092852900028704_ref028","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.153.6.765","article-title":"Relation of serum valproate concentration to response in mania","volume":"153","author":"Bowden","year":"1996","journal-title":"Am J Psychiatry"},{"key":"S1092852900028704_ref019","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.3.588"},{"key":"S1092852900028704_ref044","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"S1092852900028704_ref066","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00606.x"},{"key":"S1092852900028704_ref022","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"S1092852900028704_ref026","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"S1092852900028704_ref012","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carba-mazepine capsules as monontherapy in patients with manic or mixed bipolar disorder","author":"Weisler","journal-title":"J Clin Psychiatry"},{"key":"S1092852900028704_ref081","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.2001.0536"},{"key":"S1092852900028704_ref088","first-page":"13","article-title":"Interaction of zonisamide with benzodiazepine and GABA receptors in rat brain","volume":"39","author":"Mimaki","year":"1990","journal-title":"Med J Osaka Univ."},{"key":"S1092852900028704_ref072","first-page":"1721","article-title":"Bilateral angle-closure glaucoma and ciliary body swelling from topiramate","volume":"119","author":"Rhee","year":"2001","journal-title":"Arch Ophthalmol."},{"key":"S1092852900028704_ref042","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.505"},{"key":"S1092852900028704_ref010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/ajp.143.1.29","article-title":"Antidepressant effects of carbamazepine","volume":"143","author":"Post","year":"1986","journal-title":"Am J Psychiatry"},{"key":"S1092852900028704_ref070","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80006-9"},{"key":"S1092852900028704_ref094","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.14.1820"},{"key":"S1092852900028704_ref099","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200202"},{"key":"S1092852900028704_ref059","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00492-4"},{"key":"S1092852900028704_ref047","first-page":"A175","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs commonly used in Germany: adult and pediatric incidence estimates from registry and prescription data [abstract]","volume":"58","author":"Messenheimer","year":"2002","journal-title":"Neurology"},{"key":"S1092852900028704_ref037","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.20305.x"},{"key":"S1092852900028704_ref060","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.01190.x"},{"key":"S1092852900028704_ref055","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0210"},{"key":"S1092852900028704_ref006","first-page":"35","article-title":"Time course of clinical effects of carbamazepine: implications for mechanisms of action","volume":"49","author":"Post","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"S1092852900028704_ref013","article-title":"A 6-month, multicenter, open-label evaluation of beaded, extended release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes","author":"Ketter","journal-title":"J Clin Psychiatry"},{"key":"S1092852900028704_ref038","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00004"},{"key":"S1092852900028704_ref030","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390114"},{"key":"S1092852900028704_ref001","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"S1092852900028704_ref002","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.12.1"},{"key":"S1092852900028704_ref007","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014814924965"},{"key":"S1092852900028704_ref008","first-page":"63","volume-title":"Mania: Clinical and Research Perspectives","author":"Ketter","year":"1998"},{"key":"S1092852900028704_ref005","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199009000-00008"},{"key":"S1092852900028704_ref100","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.3.463"},{"key":"S1092852900028704_ref009","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1969.hed0901054.x"},{"key":"S1092852900028704_ref014","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00007"},{"key":"S1092852900028704_ref015","first-page":"198","article-title":"Principles of clinically important drug interactions with carbamazepine. Part I","volume":"11","author":"Ketter","year":"1991","journal-title":"J Clin Psychopharmacol."},{"key":"S1092852900028704_ref016","first-page":"306","article-title":"Principles of clinically important drug interactions with carbamazepine. Part II","volume":"11","author":"Ketter","year":"1991","journal-title":"J Clin Psychopharmacol."},{"key":"S1092852900028704_ref017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1176\/ajp.152.3.413","article-title":"Blood dyserasias with carbamazepine and valproate: a pharma-coepidemiological study of 2,228 patients at risk","volume":"152","author":"Tohen","year":"1995","journal-title":"Am J Psychiatry"},{"key":"S1092852900028704_ref018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209103271104"},{"key":"S1092852900028704_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00075-6"},{"key":"S1092852900028704_ref021","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"S1092852900028704_ref023","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.11.1652"},{"key":"S1092852900028704_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(93)90010-B"},{"key":"S1092852900028704_ref089","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701941"},{"key":"S1092852900028704_ref025","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00434-7"},{"key":"S1092852900028704_ref027","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1202"},{"key":"S1092852900028704_ref031","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.10.5768"},{"key":"S1092852900028704_ref029","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(97)00084-3"},{"key":"S1092852900028704_ref032","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00010"},{"key":"S1092852900028704_ref033","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200008000-00011"},{"key":"S1092852900028704_ref035","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00934.x"},{"key":"S1092852900028704_ref036","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1837"},{"key":"S1092852900028704_ref040","first-page":"119","article-title":"Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder","volume":"38","author":"Xie","year":"1998","journal-title":"Neuro psychobiology"},{"key":"S1092852900028704_ref041","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01251.x"},{"key":"S1092852900028704_ref045","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1106"},{"key":"S1092852900028704_ref046","unstructured":"Bowden C , Calabrese J , Ascher J , et al. Spectrum of efficacy of lamotrigine in bipolar disorder: overview of double-blind placebo-controlled studies. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 1014, 2000; San Juan, PR."},{"key":"S1092852900028704_ref082","volume-title":"Physicians' Desk Reference","year":"2003"},{"key":"S1092852900028704_ref048","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1110"},{"key":"S1092852900028704_ref052","doi-asserted-by":"publisher","DOI":"10.5414\/CPP38540"},{"key":"S1092852900028704_ref057","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(97)00045-4"},{"key":"S1092852900028704_ref058","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.3.473"},{"key":"S1092852900028704_ref061","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13370-3"},{"key":"S1092852900028704_ref062","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200106000-00015"},{"key":"S1092852900028704_ref063","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00021"},{"key":"S1092852900028704_ref067","volume-title":"Topiramate in the treatment of bulimia nervosa: additional efficacy","author":"Reimherr","year":"2002"},{"key":"S1092852900028704_ref068","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.255"},{"key":"S1092852900028704_ref074","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02087.x"},{"key":"S1092852900028704_ref075","doi-asserted-by":"publisher","DOI":"10.3109\/10401239809147036"},{"key":"S1092852900028704_ref076","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00407-4"},{"key":"S1092852900028704_ref077","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1107"},{"key":"S1092852900028704_ref083","first-page":"149","article-title":"Adjunctive oxcatbazepine in affective disorder with hyponatremic seizure: case analysis [abstract]","volume":"43","author":"Kaufman","year":"2002","journal-title":"Epilepsia"},{"key":"S1092852900028704_ref079","first-page":"83","article-title":"Studies with (Trileptal) oxcarbazepine in acute mania","volume":"5","author":"Emrich","year":"1990","journal-title":"Int Clin Psychopharmacology"},{"key":"S1092852900028704_ref053","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90130-7"},{"key":"S1092852900028704_ref080","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1993.tb04106.x"},{"key":"S1092852900028704_ref085","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1992.tb05051.x"},{"key":"S1092852900028704_ref087","first-page":"192","article-title":"Zonisamide: a new antiepileptic drug","volume":"22","author":"Oommen","year":"1999","journal-title":"Clin Neuropharmacol."},{"key":"S1092852900028704_ref091","volume-title":"The effect of zonisamide administration on patient weight","author":"Morris","year":"2000"},{"key":"S1092852900028704_ref092","volume-title":"Zonisamide in obesity: a 16-week randomized trial","author":"Gadde","year":"2002"},{"key":"S1092852900028704_ref093","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0278-5846(94)90078-7","article-title":"The first open study of zon-isamide, a novel anticonvulsant, shows efficacy in mania","volume":"18","author":"Kanba","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"S1092852900028704_ref050","volume-title":"Incidence of rash after rapid reintroduction of lamotrigine","author":"Masia","year":"2003"},{"key":"S1092852900028704_ref095","volume-title":"Weight loss during first two months of open adjunctive zonisamide for obesity in bipolat disorder patients","author":"Yang","year":"2003"},{"key":"S1092852900028704_ref071","doi-asserted-by":"publisher","DOI":"10.3109\/10401230109147382"},{"key":"S1092852900028704_ref096","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00587-2"},{"key":"S1092852900028704_ref101","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0408"},{"key":"S1092852900028704_ref011","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1176\/ajp.145.9.1104","article-title":"Lack of efficacy of carbamazepine in the treatment of panic disorder","volume":"145","author":"Uhde","year":"1988","journal-title":"Am J Psychiatry"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852900028704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T22:14:09Z","timestamp":1557180849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852900028704\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":101,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1092852900028704"],"URL":"https:\/\/doi.org\/10.1017\/s1092852900028704","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}